Breaking News Instant updates and real-time market news.

CI

Cigna

$167.31

-6.05 (-3.49%)

, ESRX

Express Scripts

$78.25

-2.5 (-3.10%)

07:44
03/13/18
03/13
07:44
03/13/18
07:44

Cigna initiated with a Market Perform at Bernstein

Bernstein analyst Lance Wilkes initiated Cigna (CI) with a Market Perform rating and $195 price target following Cigna's announcement that it will buy Express Scripts (ESRX) for $67B. Wilkes views the deal as a bet that change comes more slowly to healthcare, and that financial returns from this deal will fund future strategic acquisitions for Cigna. In a research note to investors, Wilkes said he believes disruption is coming more quickly, in PBM and pharmacy and in the shift to value, and is "skeptical" of this move by Cigna. The analyst expects earnings growth to slow for Cigna driven by its employer focus, lack of scale and already best in class margins, and added that he has a "negative" outlook for Express Scripts, expecting declining gross margins as they lose Anthem (ANTM) and client pricing pressure as focus increases on drug costs.

CI

Cigna

$167.31

-6.05 (-3.49%)

ESRX

Express Scripts

$78.25

-2.5 (-3.10%)

ANTM

Anthem

$229.86

-2.94 (-1.26%)

  • 13

    Mar

  • 02

    May

CI Cigna
$167.31

-6.05 (-3.49%)

03/12/18
LEER
03/12/18
NO CHANGE
LEER
Diplomat Pharmacy may be next takeover target, says Leerink
Leerink analyst David Larsen believes Diplomat Pharmacy (DPLO) could be the next takeover target following last week's buyout of Express Scripts (ESRX). A managed care plan or large pharmacy chain may find Diplomat's portfolio compelling, Larsen told investors earlier in a research note. He believes the rally post Cigna's (CI) acquisition of Express Scripts reflects a higher likelihood of a takeover, but that "significant upside" potential remains in Diplomat shares.
03/12/18
03/12/18
UPGRADE
Target $80

Market Perform
Express Scripts upgraded to Market Perform at Bernstein
As previously reported, Bernstein analyst Lance Wilkes upgraded Express Scripts (ESRX) to Market Perform from Underperform, stating that while he continues to be bearish on the underlying business, he views the deal to be acquired by Cigna (CI) for approximately $91 per share as a "very positive outcome." He would expect regulatory approval based upon lack of overlap, though Wilkes thinks it will likely be an extended regulatory process.
03/09/18
JPMS
03/09/18
NO CHANGE
JPMS
Overweight
JPMorgan sees opportunity in Cigna after yesterday's selloff
JPMorgan analyst Gary Taylor views Cigna's (CI) acquisition of Express Scripts (ESRX), which drove an 11.5% pullback in the shares yesterday, as a "primarily defensive deal, possibly rushed, reflecting a fairly sizable strategic turn for both companies." The analyst says that barring a complete collapse of pharmacy benefit manager or health plan margins over the next few years, he can make a "substantial upside case" for the shares of Cigna. The "sizable" free cash flow generation potential of the company is likely being underappreciated, Taylor tells investors in a research note. He keeps an Overweight rating on Cigna.
03/09/18
SBSH
03/09/18
NO CHANGE
SBSH
Buy
Cigna 11% selloff yesterday overdone, says Citi
Citi analyst Ralph Giacobbe says that while "some level" of pullback on the Express Scripts (ESRX) acquisition is understanding, the 11% selloff yesterday in shares of Cigna (CI) is overdone. The analyst remains surprised with the deal, particularly after management recently reiterated to him a model of virtual vertical integration. Giacobbe does, however, see strategic merit in the deal, while acknowledging "some level of uncertainty around retention." He keeps a Buy rating on Cigna shares.
ESRX Express Scripts
$78.25

-2.5 (-3.10%)

03/12/18
BERN
03/12/18
UPGRADE
BERN
Market Perform
Express Scripts upgraded to Market Perform from Underperform at Bernstein
ANTM Anthem
$229.86

-2.94 (-1.26%)

03/09/18
LEER
03/09/18
NO CHANGE
Target $335
LEER
Outperform
Leerink sees favorable risk/reward on Anthem, ups target to $335
Leerink analyst Ana Gupte raised her price target for Anthem to $335 from $325 citing increased conviction on the company's favorable risk/reward in the managed care organization group. Near-term fears of flu in Q1 and accelerating cost trend are overblown, Gupte tells investors in a research note. After hosting meetings with management, the analyst reiterates her above consensus estimates on Anthem and Outperform rating.
03/08/18
JEFF
03/08/18
NO CHANGE
Target $248
JEFF
Buy
Cigna selloff today a buying opportunity, says Jefferies
Jefferies analyst David Windley recommends using the selloff today in shares of Cigna (CI) as a buying opportunity. The analyst estimates low- to mid-teens earnings accretion through 2021 from the Express Scripts (ESRX) acquisition, essentially matching management's target. Windley believes Cigna's customer retention guidance caused some confusion. He notes that management's guidance assumes Anthem (ANTM) is out in all years. The analyst keeps a Buy rating on Cigna with a $248 price target.
03/08/18
LEHM
03/08/18
INITIATION
Target $270
LEHM
Overweight
Anthem initiated with an Overweight at Barclays
Barclays analyst Steve Valiquette started Anthem with an Overweight rating and $270 price target. The analyst initiated 14 companies in Health Care Services with a Neutral industry view.
02/01/18
FBCO
02/01/18
NO CHANGE
Target $280
FBCO
Outperform
Anthem price target raised to $280 from $255 at Credit Suisse
Credit Suisse analyst A.J. Rice raised his price target for Anthem to $280 from $255 on "strong" operating momentum with numerous developing opportunities. The analyst reiterates an Outperform rating on the shares.

TODAY'S FREE FLY STORIES

CHK

Chesapeake

$2.39

-0.19 (-7.36%)

12:20
12/14/18
12/14
12:20
12/14/18
12:20
Options
Ratio put spread in Chesapeake as shares drop 7.3% and fall to 52-week lows »

Ratio put spread in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
12/14/18
12/14
12:17
12/14/18
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
12/14/18
12/14
12:16
12/14/18
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$133.26

-14.54 (-9.84%)

, SBUX

Starbucks

$64.61

-2.29 (-3.42%)

12:15
12/14/18
12/14
12:15
12/14/18
12:15
On The Fly
Fly Intel: Wall Street's top stories at midday »

Stocks opened lower…

JNJ

Johnson & Johnson

$133.26

-14.54 (-9.84%)

SBUX

Starbucks

$64.61

-2.29 (-3.42%)

ADBE

Adobe

$233.37

-14.34 (-5.79%)

COST

Costco

$207.71

-18.7 (-8.26%)

BEL

Belmond

$24.67

7 (39.62%)

LVMUY

LVMH

$0.00

(0.00%)

KANG

iKang Healthcare

$20.30

2.03 (11.11%)

IDRA

Idera Pharmaceuticals

$5.34

-1.26 (-19.09%)

CDE

Coeur Mining

$3.89

-0.165 (-4.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 14

    Dec

PFE

Pfizer

$43.45

-1.105 (-2.48%)

12:14
12/14/18
12/14
12:14
12/14/18
12:14
Hot Stocks
Pfizer announces new $10B share repurchase program »

The board of directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

PFE

Pfizer

$43.52

-1.03 (-2.31%)

12:13
12/14/18
12/14
12:13
12/14/18
12:13
Hot Stocks
Pfizer raises quarterly dividend 6% to 36c per share »

The board of directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

PFE

Pfizer

$43.52

-1.03 (-2.31%)

12:12
12/14/18
12/14
12:12
12/14/18
12:12
Hot Stocks
Breaking Hot Stocks news story on Pfizer »

Pfizer boosts dividend to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

ECA

Encana

$5.93

-0.295 (-4.74%)

12:10
12/14/18
12/14
12:10
12/14/18
12:10
Options
Call buyers in Encana as shares suffer additional losses »

Call buyers in Encana as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TNXP

Tonix Pharmaceuticals

$2.76

0.02 (0.73%)

12:08
12/14/18
12/14
12:08
12/14/18
12:08
Hot Stocks
CVI Investments reports 9.9% passive stake in Tonix Pharmaceuticals »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CYH

Community Health

$3.94

-0.45 (-10.25%)

12:00
12/14/18
12/14
12:00
12/14/18
12:00
Hot Stocks
Community Health falls -10.2% »

Community Health is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$132.65

-15.15 (-10.25%)

12:00
12/14/18
12/14
12:00
12/14/18
12:00
Hot Stocks
Johnson & Johnson falls -10.3% »

Johnson & Johnson is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UGAZ

VelocityShares 3x Long Natural Gas ETN

$101.00

-17 (-14.41%)

12:00
12/14/18
12/14
12:00
12/14/18
12:00
Hot Stocks
VelocityShares 3x Long Natural Gas ETN falls -14.4% »

VelocityShares 3x Long…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CIVI

Civitas Solutions

$14.68

2.05 (16.23%)

12:00
12/14/18
12/14
12:00
12/14/18
12:00
Hot Stocks
Civitas Solutions rises 14.6% »

Civitas Solutions is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Mar

SPY

SPDR S&P 500 ETF Trust

$262.10

-3.31 (-1.25%)

12:00
12/14/18
12/14
12:00
12/14/18
12:00
Options
$10.5M sweep of SPDR 500 Trust upside calls »

$10.5M sweep of SPDR 500…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DGAZ

VelocityShares 3x Inv Natural Gas ETN

$73.25

9.63 (15.14%)

12:00
12/14/18
12/14
12:00
12/14/18
12:00
Hot Stocks
VelocityShares 3x Inv Natural Gas ETN rises 14.7% »

VelocityShares 3x Inv…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BEL

Belmond

$24.69

7.015 (39.70%)

12:00
12/14/18
12/14
12:00
12/14/18
12:00
Hot Stocks
Belmond rises 39.8% »

Belmond is up 39.8%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNE

Sony

$51.75

-0.45 (-0.86%)

, T

AT&T

$30.21

0.3 (1.00%)

11:56
12/14/18
12/14
11:56
12/14/18
11:56
On The Fly
Box Office Battle: 'Spider-Man: Into the Spider-Verse' swings into theaters »

Welcome to "Box Office…

SNE

Sony

$51.75

-0.45 (-0.86%)

T

AT&T

$30.21

0.3 (1.00%)

CMCSA

Comcast

$36.68

-0.07 (-0.19%)

CMCSK

Comcast

$0.00

(0.00%)

DIS

Disney

$113.21

-0.17 (-0.15%)

FOXA

21st Century Fox

$49.26

0.13 (0.26%)

FOX

21st Century Fox

$49.02

0.14 (0.29%)

LGF.A

Lionsgate

$16.00

0.25 (1.59%)

LGF.B

Lionsgate

$14.90

0.3 (2.05%)

VIA

Viacom

$31.85

0.22 (0.70%)

VIAB

Viacom

$29.28

0.41 (1.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 23

    Jan

  • 30

    Jan

  • 20

    Mar

EPD

Enterprise Products

$26.15

-0.15 (-0.57%)

11:55
12/14/18
12/14
11:55
12/14/18
11:55
Options
Enterprise Products put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

NTR

Nutrien

$47.01

-0.02 (-0.04%)

11:49
12/14/18
12/14
11:49
12/14/18
11:49
Hot Stocks
Nutrien increases existing share repurchase program »

Nutrien announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LNC

Lincoln National

$54.54

0.11 (0.20%)

11:48
12/14/18
12/14
11:48
12/14/18
11:48
Hot Stocks
Lincoln Financial appoints Leon Roday as General Counsel »

Lincoln Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$131.24

-16.56 (-11.20%)

11:44
12/14/18
12/14
11:44
12/14/18
11:44
Recommendations
Johnson & Johnson analyst commentary  »

J&J $40B loss in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SWFT

Swift Transportation

$0.00

(0.00%)

, WERN

Werner

$30.52

-0.48 (-1.55%)

11:41
12/14/18
12/14
11:41
12/14/18
11:41
Hot Stocks
DOJ sues freight companies for systematic overcharging of shipments »

The United States has…

SWFT

Swift Transportation

$0.00

(0.00%)

WERN

Werner

$30.52

-0.48 (-1.55%)

JBHT

J.B. Hunt

$93.32

-2.57 (-2.68%)

ODFL

Old Dominion

$125.75

-0.79 (-0.62%)

KNX

Knight-Swift

$26.88

-0.44 (-1.61%)

ARCB

ArcBest

$35.22

-0.38 (-1.07%)

YRCW

YRC Worldwide

$4.13

-0.3 (-6.77%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOW

Lowe's

$93.98

-0.37 (-0.39%)

11:40
12/14/18
12/14
11:40
12/14/18
11:40
Options
Lowes calls active »

Lowes calls active.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

JNJ

Johnson & Johnson

$132.94

-14.86 (-10.05%)

11:38
12/14/18
12/14
11:38
12/14/18
11:38
Recommendations
Johnson & Johnson analyst commentary  »

Johnson & Johnson…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LPTX

Leap Therapeutics

$2.92

0.07 (2.46%)

11:36
12/14/18
12/14
11:36
12/14/18
11:36
Conference/Events
Leap Therapeutics to hold a conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.